Table 5.
Lymph node metastases (7/48 patients): PLA, pelvic lymphadenectomy; PALA, para-aortic lymphadenectomy; +, positive histopathology; -, negative histopathology.
| Case | Age | Initial Stage | Pelvic SLN | PLA | Para-Aortic SLN | PALA | ILV | Final FIGO Stage | |
|---|---|---|---|---|---|---|---|---|---|
| Tc99 | ICG | ||||||||
| 1 | 75 | IaG3 (Serous) | + Unilat (1/2) | + Unilat (1/2) | - | No injection (IMC 47) | Not done | + | IIIC1 |
| 2 | 67 | Ia G3 (Serous) | + Unilat (1/2) | + Unilat (1/2) | - | No detected | - | + | IIIC1 |
| 3 | 56 | Ia/b G1 (Endometrioid) | + R (itc) + L (micro) |
+ R (itc) + L (micro) |
- | No injection | - | + | IIIC1 G2 |
| 4 | 69 | IbG3 (Endometrioid) | + R (1/3) + L (2/2) |
− R (0/2) + L (2/2) |
- | No detected | + (2/8) | + | IIIC2 |
| 5 | 52 | IbG3 (Endometrioid) | + Unilat (1/2) | + Unilat (1/2) | - | No detected | + (2/9) | + | IIIC2 |
| 6 | 78 | IaG3 (Serous) | - | - | - | No detected | + (2/6) | + | IIIC (Fallopian Tube) |
| 7 | 75 | IbG3 (Serous) | - | - | - | No detected | + 2 bulky | + | IIIC2 |